“Investigation of dual anti-HIV/HSV activity of oxoquinoline-acylhydrazone derivatives by molecular docking” (2023) Brazilian Journal of Pharmaceutical Sciences, 59, p. e23263. doi:10.1590/s2175-97902023e23263.